Cell Biosciences ‘converge’ in $12m acquisition.
Cell Biosciences plans to gain ground in the protein-based drugs market by acquiring Convergent Bioscience at the end of October for a cash sum of $12m (€8.6m.)
Archives for October 18, 2010
Week-long anti-counterfeiting effort confiscates 1m pills
A week of global anti-counterfeiting law enforcement coordinated by Interpol led to the shutdown of 290 websites, seizure of 11,000 packages and confiscation of 1m pills.
SGS aims to lead biologics testing by 2014
SGS Life Sciences will roll out new biologics testing capabilities across its network in bid to be the world’s number one contract biopharmaceuticals testing laboratory by 2014.
Southern Research gains bioanalytical lab assets in BioCryst acquisition
Southern Research Institute is acquiring BioCryst Pharmaceuticals’ bioanalytical laboratory assets and personnel in a move towards expanding its bioanalytical service offerings.
ShangPharma beats IPO forecast and plans Fengxian facility
ShangPharma has raised $87m through an IPO on the New York Stock Exchange according to a Bloomberg report, beating the $46m to $53m the Chinese CRO forecast.
WR Grace’s acquisition of Synthetech approved by US Bankruptcy Court
Industrial catalysis firm WR Grace has been OKed to acquire fine chemicals group Synthetech by the US Bankruptcy Court.
Appointments at AMRI, Novella Clinical, BioClinica and Idis – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at AMRI, Novella Clinical, BioClinica and Idis.
Microscan adds track and trace label verification system
Microscan has introduced a system for inspecting and verifying package label content that can be implemented with the minimum of cost and effort.
Respiratory drugs a particular* opportunity for processing tech says Prosonix
Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.